NASDAQ:ADVB Advanced Biomed Q4 2026 Earnings Results & Report $4.90 -0.24 (-4.67%) As of 04:00 PM Eastern This is a fair market value price provided by Massive. Learn more. Advanced Biomed reported Q4 2026 earnings on October 13, 2026. The company reported EPS of $0.4440. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ4 2026Report DateOctober 13, 2026TimeAfter Market Closes Advanced Biomed EPS ResultsActual EPS$0.4440Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AAdvanced Biomed Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AConference Call ResourcesEarnings HistoryCompany Profile Advanced Biomed Q4 2026 Earnings FAQ Did Advanced Biomed beat earnings estimates for Q4 2026? Advanced Biomed (NASDAQ:ADVB) reported earnings of $0.4440 per share for Q4 2026. The report was announced on Tuesday, October 13, 2026. Advanced Biomed Earnings HeadlinesAdvanced Biomed Delays Annual 10-K FilingSeptember 28, 2026 | tipranks.comAdvanced Biomed Inc ADVBJuly 26, 2026 | morningstar.comMTicker Revealed: Pre-IPO Access to "Next Elon Musk" CompanyWe’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billion in government contracts. Peter Thiel just bet $1 Billion on it.October 15 at 1:00 AM | Banyan Hill Publishing (Ad)ADVB Advanced Biomed Inc.July 22, 2026 | seekingalpha.comAdvanced Biomed stock is surging: Here's why it is trendingJuly 22, 2026 | msn.com3 Top-Traded Penny Stocks to Watch Today, 7/21/2026July 21, 2026 | tipranks.comSee More Advanced Biomed Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Advanced Biomed? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Advanced Biomed and other key companies, straight to your email. Email Address About Advanced BiomedAdvanced Biomed (NASDAQ:ADVB) is a clinical-stage biopharmaceutical company focused on developing radiopharmaceutical products for the diagnosis and treatment of cancer. The company’s research is centered on radioligand therapies, which use targeting molecules to deliver radioactive substances directly to cancer cells. Its development programs include products designed to target prostate-specific membrane antigen (PSMA), an established target in prostate cancer. Advanced Biomed’s programs remain subject to clinical development and regulatory review. Publicly available information about the company’s broader commercial operations, geographic reach, and leadership is limited.View Advanced Biomed ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Apple Cut iPhone 18 Orders; What Does It Mean For Suppliers?Domino’s Pizza: As Cheap As It Gets, Nowhere to Go But UpFastenal Flashes Bullish Signal as Uptrend Holds Despite Margin PressureASML Can’t Keep Up With AI Demand—Why That's a Good ThingCiti Stock Falls Despite Earnings Beat: What Investors Need to KnowDon’t Get NVIDIA’s Reflection AI Interest Wrong: Its Moat Could DeepenBig Banks Report Strong Earnings—So Why Are Shares Falling? Upcoming Earnings Truist Financial (10/16/2026)Travelers Companies (10/16/2026)HDFC Bank (10/17/2026)ICICI Bank (10/17/2026)America Movil (10/20/2026)Netflix (10/20/2026)General Motors (10/20/2026)Chubb (10/20/2026)Capital One Financial (10/20/2026)Intuitive Surgical (10/20/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
